Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01559194 · ClinicalTrials.gov registry record · Phase 3
Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk
A Phase 3 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 82
- Enrollment target
NCT01559194: Completed Phase 3 study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01559194 is a Phase 3 study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 82 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01559194, a Phase 3 study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 82 participants
- Enrollment target
Study Summary
The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.
Interventions
- BEHAVIORAL Low Fat Diet plus exercise
- BEHAVIORAL Low Carbohydrate diet + Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
What the finished NCT01559194 record still lists
NCT01559194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Fat Diet plus exercise is the first listed.
NCT01559194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01559194 about?
NCT01559194 is a clinical study titled "Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk". The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.
What is the current status of trial NCT01559194?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 82 participants. The study started on 2005-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT01559194?
The interventions under investigation include: Low Fat Diet plus exercise (BEHAVIORAL), Low Carbohydrate diet + Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01559194?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01559194's enrollment target sits among peer trials
82 1752nd of 2000 higher than 249 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia